Buy KPV Tablets | KPV Tablets for sale | KPV Tablets delivery
KPV Peptide – Encapsulated Research Material
KPV is a short tripeptide composed of the amino acids lysine, proline, and valine and corresponds to a C-terminal fragment of alpha-melanocyte-stimulating hormone (α-MSH). In laboratory research contexts, KPV is examined as a sequence-specific peptide fragment to support studies focused on peptide structure, molecular comparison, and fragment-level analysis relative to its parent sequence.
Within non-human experimental systems, KPV is frequently referenced in comparative peptide research, where investigators evaluate how small peptide fragments differ from full-length parent compounds in terms of molecular composition, receptor interaction profiles, and analytical behavior under controlled laboratory conditions. These investigations are conducted strictly within research and characterization frameworks and do not imply biological outcomes or applications.
Best KPV Tablets online | KPV Tablets store | Quality KPV Tablets for sale online
The encapsulated presentation is provided to support standardized material handling, storage consistency, and batch uniformity during laboratory workflows. This format is intended solely for research material management and does not indicate a route of administration, biological application, or experimental outcome.
KPV is supplied exclusively for in vitro research, analytical testing, and non-human experimental use by qualified professionals operating within compliant laboratory environments. It is not intended for human use, animal use, diagnostic use, or therapeutic application.
Chemical & Analytical Characteristics:
| Characteristic | Details |
|---|---|
| Chemical Sequence | Â Lysine-Proline-Valine (Lys-Pro-Val or KPV) |
| CAS Number | 67727-97-3 |
| Molecular Formula | C17H31N3O4 |
| Molecular Weight | 342.43 g/mol |
| Alternative Scientific References | KPV tripeptide; Lys–Pro–Val; α-MSH (11–13) (sequence reference); KPV peptide |












Reviews
There are no reviews yet.